Freenome

Freenome is a private biotech company developing blood tests for early cancer detection using multiomics technology and artificial intelligence. Their intelligent screening platform aims to detect cancer in its earliest, most treatable stages through a standard blood draw. The company runs rigorous clinical research programs to drive discovery, development, and validation of its tests.